ViaCyte funding for functional Type 1 cure
ViaCyte has closed a $45m Series D financing tranche in the United States, bringing the total round to more than $115m, reports DrugDeliveryBusiness.com. The funding will
ViaCyte has closed a $45m Series D financing tranche in the United States, bringing the total round to more than $115m, reports DrugDeliveryBusiness.com. The funding will
As reported by Andy Coghlan in New Scientist “In early August 2017, two people with Type 1 diabetes became the first to receive implants containing